BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 31295533)

  • 1. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
    Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
    J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
    Xin Y; Xu L; Zhang X; Yang C; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Mar; 544():44-51. PubMed ID: 33516881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease.
    Pan Z; Guo J; Tang K; Chen Y; Gong X; Chen Y; Zhong Y; Xiao X; Duan S; Cui T; Wu X; Zhong Y; Yang X; Shen C; Gao Y
    J Agric Food Chem; 2022 Nov; 70(44):14220-14234. PubMed ID: 36300841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
    You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
    J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
    Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
    Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G
    Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.
    Morel C; Chowdhary V; Thevkar Nagesh P; Ribeiro M; Hawryluk D; Catalano D; Adorini L; Szabo G
    Liver Int; 2023 Jan; 43(1):100-114. PubMed ID: 35869657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
    Ka SO; Bang IH; Bae EJ; Park BH
    FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
    Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.
    Wang Z; Dou X; Li S; Zhang X; Sun X; Zhou Z; Song Z
    Hepatology; 2014 Apr; 59(4):1381-92. PubMed ID: 24170703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.
    Ramirez T; Li YM; Yin S; Xu MJ; Feng D; Zhou Z; Zang M; Mukhopadhyay P; Varga ZV; Pacher P; Gao B; Wang H
    J Hepatol; 2017 Mar; 66(3):601-609. PubMed ID: 27871879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Sirt6 activation abrogates acute liver failure.
    Luo J; Liu H; Xu Y; Yu N; Steiner RA; Wu X; Si S; Jin ZG
    Cell Death Dis; 2024 Apr; 15(4):283. PubMed ID: 38649362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
    Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
    Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT6 protects against hepatic ischemia/reperfusion injury by inhibiting apoptosis and autophagy related cell death.
    Zhang S; Jiang S; Wang H; Di W; Deng C; Jin Z; Yi W; Xiao X; Nie Y; Yang Y
    Free Radic Biol Med; 2018 Feb; 115():18-30. PubMed ID: 29129519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms.
    Wang XX; Wang XL; Tong MM; Gan L; Chen H; Wu SS; Chen JX; Li RL; Wu Y; Zhang HY; Zhu Y; Li YX; He JH; Wang M; Jiang W
    Basic Res Cardiol; 2016 Mar; 111(2):13. PubMed ID: 26786260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
    Yin H; Hu M; Liang X; Ajmo JM; Li X; Bataller R; Odena G; Stevens SM; You M
    Gastroenterology; 2014 Mar; 146(3):801-11. PubMed ID: 24262277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice.
    Liu S; Yeh TH; Singh VP; Shiva S; Krauland L; Li H; Zhang P; Kharbanda K; Ritov V; Monga SP; Scott DK; Eagon PK; Behari J
    Hepatology; 2012 Mar; 55(3):931-40. PubMed ID: 22031168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
    Ceni E; Mello T; Galli A
    World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of SIRT6 in nonalcoholic steatohepatitis].
    Jing XD; Tang Q; He JH
    Sheng Li Xue Bao; 2021 Oct; 73(5):745-754. PubMed ID: 34708231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients.
    Marquardt JU; Fischer K; Baus K; Kashyap A; Ma S; Krupp M; Linke M; Teufel A; Zechner U; Strand D; Thorgeirsson SS; Galle PR; Strand S
    Hepatology; 2013 Sep; 58(3):1054-64. PubMed ID: 23526469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.